Skip to product information
Tirzepatide
Tirzepatide brings two incretin pathways together in a single molecule, activating both the GIP and the GLP-1 receptor. That dual-agonist character is exactly why laboratories reach for it when modelling multi-pathway metabolic signalling, receptor pharmacology and gut-brain crosstalk.
Each vial is a lyophilised powder verified to ≥99% purity by HPLC, with a Certificate of Analysis on request. UK-based dispatch, strictly for preclinical and laboratory research.
⚡ Same-day dispatch
Order before 12pm for same-day dispatch — Royal Mail 24, next-day UK delivery.
✓
Multibuy Discount Available
Buy 2 save 5%
Buy 3 save 10%
Buy 4 save 15%
Buy 5+ save 20%
£50.00
Sale price
£50.00
Regular price
£70.00
✓ 99%+ Purity Guaranteed
✓ COA Available
✓ Same Day UK Dispatch
✓ Secure Checkout
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use. Read full disclaimer →
- Dual GIP/GLP-1 receptor agonism and binding-kinetics assays
- Side-by-side studies against single-agonist GLP-1 peptides
- Insulin secretion and metabolic pathway modelling
- Appetite and gut-brain axis signalling research
- Pancreatic beta-cell function investigations
For laboratory research use only. Not for human or veterinary use.
- Form: Lyophilised powder
- Purity: ≥99% (HPLC verified)
- Storage: −20°C, protected from light and moisture
- Available sizes: 10mg · 15mg · 20mg · 30mg · 40mg · 50mg · 60mg
- Certificate of Analysis: available on request